Labcorp stock gets a clear October 28 earnings date
Published on 10/05/2026 at 21:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp stock (ISIN US5049221055) was trading at USD 309.62 on the NYSE on October 5, 2026, at 3:26 p.m. ET, up 0.37 percent from the prior close. According to Labcorp on September 30, the company will publish third-quarter 2026 results before the market opens on October 28 and host a webcast at 9:00 a.m. ET.
October 28 sets the next checkpoint
The scheduled report follows a second quarter in which revenue increased 6 percent to USD 3.7 billion, margins improved 70 basis points to 15.8 percent and adjusted EPS rose 15 percent to USD 4.99. Fortune reported those figures for the quarter ended June 30, 2026.
The operating mix also matters for the October update: Diagnostics revenue increased 5.5 percent to USD 2.9 billion, while Biopharma Laboratory Services revenue increased 6.5 percent to USD 836 million in Q2 2026, according to Fortune.
Guidance points to measured growth
At its September 10 investor day, Labcorp reaffirmed 2026 enterprise revenue guidance of USD 14.710 billion to USD 14.827 billion, implying growth of 5.4 percent to 6.3 percent. The same release set adjusted EPS guidance at USD 18.10 to USD 18.55 and free cash flow guidance at USD 1.240 billion to USD 1.360 billion, according to Labcorp.
The longer-term plan calls for compound annual revenue growth of 5 percent to 8 percent through 2029 and adjusted EPS growth of 8.5 percent to 11.5 percent. Labcorp also expects adjusted operating margin expansion of 75 to 150 basis points by the end of 2029, keeping execution and reimbursement pressure central to the next results discussion.
Analyst target exceeds the market price
MarketBeat reported on October 1 that 12 analysts had a Moderate Buy consensus, with nine Buy ratings and three Holds. Their average 12-month target of USD 337.73 is 9.1 percent above Labcorp's USD 309.62 price on October 5, 2026.
Stock remains below its yearly high
Labcorp was trading at USD 309.62 on the NYSE on October 5, 2026, at 3:26 p.m. ET. The session range was USD 305.96 to USD 309.84, while the 52-week range stood at USD 244.52 to USD 341.80 and market capitalization was USD 25.4 billion.
Labcorp stock facts
- Company: Labcorp Holdings Inc.
- ISIN: US5049221055
- Ticker: LH
- Trading venue: NYSE
- Price (as of October 5, 2026, 3:26 p.m. ET): USD 309.62
- Market capitalization: USD 25.4 billion (as of October 5, 2026)
- 52-week range: USD 244.52-USD 341.80 (as of October 5, 2026)
- Sector / Industry: Health Care / Laboratory Services
Upcoming dates for Labcorp stock
- October 28, 2026: Third-quarter results before the market opens and webcast at 9:00 a.m. ET
